• Vice President in Student Union of College of Foreign Languages, Nankai University, organized more than 200 sports matches, and led the Badminton team to win 1st champion in history (2016-2017) • Nominated by Prudential’s Global Finance Training Project in Hong Kong (Jan 2017) • Recommended by Barclays Bank Wall Street Financial Training Program in New York (Aug 2016) • Volunteered in L’Oreal Campus Charity Activity and sales volume of one day reached RMB 30 thousand, and was awarded National Sales Champion (May 2016)
• Submitted projects’ and meeting application, tracking project progress, sales budget and spending weekly
• Arranged internal meetings monthly, including detailed schedule, air tickets and accommodation
• Negotiated with 9 supporting departments to meet sales targets weekly
• Trained new employees with 6 online working systems and compliance regulations monthly
• Organized 5 team building projects with more than 150 people involved
Company Description
Pfizer is one of the world's largest pharmaceutical companies.It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. The company develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology. Its products include the blockbuster drug Lipitor (atorvastatin), used to lower LDL blood cholesterol; Lyrica (pregabalin) for neuropathic pain/fibromyalgia; Diflucan (fluconazole), an oral antifungal medication; Zithromax (azithromycin), an antibiotic; Viagra (sildenafil) for erectile dysfunction; and Celebrex/Celebra (celecoxib), an anti-inflammatory drug. In 2016, Pfizer Inc. was expected to merge with Allergan plc, in a deal that would have been worth $160 billion, to create the Ireland-based "Pfizer plc". The merger was called off in April 2016 because of new rules from the United States Treasury against inversions, a method of avoiding taxes by merging with a foreign company. The company has made the second-largest pharmaceutical settlement with the U.S. Department of Justice.
